---
title: "Angelalign Technology Announces Special Interim Dividend"
description: "Angelalign Technology Inc. (HK:6699) has declared a special interim dividend of HKD 0.46 per share for the six-month period ending June 30, 2025, reflecting its strong financial performance and commit"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/254465599.md"
published_at: "2025-08-25T13:40:36.000Z"
---

# Angelalign Technology Announces Special Interim Dividend

> Angelalign Technology Inc. (HK:6699) has declared a special interim dividend of HKD 0.46 per share for the six-month period ending June 30, 2025, reflecting its strong financial performance and commitment to shareholder value. The current analyst rating for the stock is a Hold, with a price target of HK$72.00. Angelalign specializes in orthodontic solutions and is recognized for its advanced clear aligner products. The company's market cap stands at HK$11.31B, with an average trading volume of 1,184,177 shares.

### Elevate Your Investing Strategy:

-   Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An update from Angelalign Technology Inc. ( (HK:6699) ) is now available.

Angelalign Technology Inc. has announced a special interim dividend of HKD 0.46 per share for the six-month period ending June 30, 2025. This announcement reflects the company’s robust financial performance and commitment to returning value to its shareholders, potentially enhancing its market position and stakeholder confidence.

The most recent analyst rating on (HK:6699) stock is a Hold with a HK$72.00 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.

**More about Angelalign Technology Inc.**

Angelalign Technology Inc. operates in the dental technology industry, specializing in orthodontic solutions. The company is known for its advanced clear aligner products, which cater to the growing demand for non-invasive dental correction solutions.

**Average Trading Volume:** 1,184,177

**Technical Sentiment Signal:** Buy

**Current Market Cap:** HK$11.31B

See more insights into 6699 stock on TipRanks’ Stock Analysis page.

## Trending Articles:

-   RDDT Lawsuit Alert! Class Action Lawsuit Against Reddit, Inc.
-   ‘Nvidia Is Best Positioned to Clear a High Bar,’ Says TD Cowen as it Raises PT Ahead of Q2 Print
-   IRBT Lawsuit Alert! Class Action Lawsuit Against iRobot Corporation

Disclaimer & DisclosureReport an Issue

### Related Stocks

- [06699.HK - ANGELALIGN](https://longbridge.com/en/quote/06699.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| AskSlim Market Week - Thursday, Feb. 13 | Photo by Nicholas Cappello on UnsplashIn this video, we dive into stock market trends, dissect key sector moves, and sha | [Link](https://longbridge.com/en/news/275943998.md) |
| Compound (COMP) – Is a major pullback next despite price gains of 23%? | Compound (COMP) recently gained 23%, but bearish signs suggest a potential price reversal. Currently trading at $20.51,  | [Link](https://longbridge.com/en/news/275985469.md) |
| Calls for stronger IP protections expected to dominate trade hearing | Parties advocating for stronger intellectual property protections are expected to take center stage at an upcoming publi | [Link](https://longbridge.com/en/news/275943141.md) |
| South Carolina sees dip in daily measles cases but too early to call slowdown, health official says | Feb 11 (Reuters) - Reported daily measles cases in South Carolina have been declining in recent days, but it is too earl | [Link](https://longbridge.com/en/news/275644487.md) |
| CPF to roll out lifecycle portfolios for those willing to take some risk for higher long-term returns | The CPF Board will introduce a new lifecycle investment scheme in early 2028 for members willing to take risks for highe | [Link](https://longbridge.com/en/news/275723963.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
